These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 25881507)

  • 21. Tumour necrosis factor-alpha and transforming growth factor-beta are significantly associated with better prognosis in non-small cell lung carcinoma: putative relation with BCL-2-mediated neovascularization.
    Boldrini L; Calcinai A; Samaritani E; Pistolesi F; Mussi A; Lucchi M; Angeletti CA; Basolo F; Fontanini G
    Br J Cancer; 2000 Aug; 83(4):480-6. PubMed ID: 10945495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of p53/p21 expression and cigarette smoking with tumor progression and poor prognosis in non-small cell lung cancer patients.
    Xie D; Lan L; Huang K; Chen L; Xu C; Wang R; Shi Y; Wu X; Wang L; Liu Y; Lu B
    Oncol Rep; 2014 Dec; 32(6):2517-26. PubMed ID: 25333671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer.
    Yang YR; Zang SZ; Zhong CL; Li YX; Zhao SS; Feng XJ
    Int J Clin Exp Pathol; 2014; 7(10):6929-35. PubMed ID: 25400777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of Ang-2 mRNA in non-small cell lung cancer: association with angiogenesis and poor prognosis.
    Takanami I
    Oncol Rep; 2004 Oct; 12(4):849-53. PubMed ID: 15375511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of dihydrodiol dehydrogenase as a prognostic marker of non-small cell lung cancer.
    Hsu NY; Ho HC; Chow KC; Lin TY; Shih CS; Wang LS; Tsai CM
    Cancer Res; 2001 Mar; 61(6):2727-31. PubMed ID: 11289154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel molecular staging protocol for non-small cell lung cancer.
    Miyake M; Adachi M; Huang C; Higashiyama M; Kodama K; Taki T
    Oncogene; 1999 Apr; 18(14):2397-404. PubMed ID: 10327061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Expression of special AT-rich sequence-binding protein mRNA and its clinicopathological significance in non-small cell lung cancer].
    Zhou LY; Liu F; Tong J; Chen QQ; Zhang FW
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Mar; 29(3):534-7. PubMed ID: 19304547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of KISS1 and MMP-9 in non-small cell lung cancer and their relations to metastasis and survival.
    Zheng S; Chang Y; Hodges KB; Sun Y; Ma X; Xue Y; Williamson SR; Lopez-Beltran A; Montironi R; Cheng L
    Anticancer Res; 2010 Mar; 30(3):713-8. PubMed ID: 20392988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LETM1 is a potential biomarker of prognosis in lung non-small cell carcinoma.
    Piao L; Yang Z; Feng Y; Zhang C; Cui C; Xuan Y
    BMC Cancer; 2019 Sep; 19(1):898. PubMed ID: 31500591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Correlations of S100A4 and MMP9 expressions to infiltration, metastasis and prognosis of non-small cell lung cancer].
    Chen XL; Wang LC; Zhang WG; Chen XY; Sun ZM
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1254-8. PubMed ID: 18676277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phosphorylated Akt expression is a prognostic marker in early-stage non-small cell lung cancer.
    Yip PY; Cooper WA; Kohonen-Corish MR; Lin BP; McCaughan BC; Boyer MJ; Kench JG; Horvath LG
    J Clin Pathol; 2014 Apr; 67(4):333-40. PubMed ID: 24265323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survivin expression impacts prognostically on NSCLC but not SCLC.
    Rosato A; Menin C; Boldrin D; Dalla Santa S; Bonaldi L; Scaini MC; Del Bianco P; Zardo D; Fassan M; Cappellesso R; Fassina A
    Lung Cancer; 2013 Feb; 79(2):180-6. PubMed ID: 23218791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prognostic significance of aldehyde dehydrogenase 1A1 (ALDH1A1) and CD133 expression in early stage non-small cell lung cancer.
    Alamgeer M; Ganju V; Szczepny A; Russell PA; Prodanovic Z; Kumar B; Wainer Z; Brown T; Schneider-Kolsky M; Conron M; Wright G; Watkins DN
    Thorax; 2013 Dec; 68(12):1095-104. PubMed ID: 23878161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PPM1D overexpression predicts poor prognosis in non-small cell lung cancer.
    Yang H; Gao XY; Li P; Jiang TS
    Tumour Biol; 2015 Mar; 36(3):2179-84. PubMed ID: 25412952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ALDH1A1-overexpressing cells are differentiated cells but not cancer stem or progenitor cells in human hepatocellular carcinoma.
    Tanaka K; Tomita H; Hisamatsu K; Nakashima T; Hatano Y; Sasaki Y; Osada S; Tanaka T; Miyazaki T; Yoshida K; Hara A
    Oncotarget; 2015 Sep; 6(28):24722-32. PubMed ID: 26160842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Over-expression of small ubiquitin-like modifier proteases 1 predicts chemo-sensitivity and poor survival in non-small cell lung cancer.
    Mu J; Zuo Y; Yang W; Chen Z; Liu Z; Tu J; Li Y; Yuan Z; Cheng J; He J
    Chin Med J (Engl); 2014; 127(23):4060-5. PubMed ID: 25430449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased expression of 17-beta-hydroxysteroid dehydrogenase type 1 in non-small cell lung cancer.
    Drzewiecka H; Gałęcki B; Jarmołowska-Jurczyszyn D; Kluk A; Dyszkiewicz W; Jagodziński PP
    Lung Cancer; 2015 Feb; 87(2):107-16. PubMed ID: 25564397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Desmoglein 3 as a prognostic factor in lung cancer.
    Fukuoka J; Dracheva T; Shih JH; Hewitt SM; Fujii T; Kishor A; Mann F; Shilo K; Franks TJ; Travis WD; Jen J
    Hum Pathol; 2007 Feb; 38(2):276-83. PubMed ID: 17084439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of p29/SYF2/fSAP29/NTC31 in the progression of NSCLC via modulating cell proliferation.
    Liu Y; Ni T; Xue Q; Lv L; Chen B; Cui X; Cui Y; Wang Y; Mao G; Ji L
    Pathol Res Pract; 2015 Jan; 211(1):36-42. PubMed ID: 25433998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MDK Protein Overexpression Correlates with the Malignant Status and Prognosis of Non-small Cell Lung Cancer.
    Yuan K; Chen Z; Li W; Gao CE; Li G; Guo G; Yang Y; Ai Y; Wu L; Zhang M
    Arch Med Res; 2015 Nov; 46(8):635-41. PubMed ID: 26656665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.